|
1
|
White NM and Yousef GM: MicroRNAs:
Exploring a new dimension in the pathogenesis of kidney cancer. BMC
Med. 8:652010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saini S, Yamamura S, Majid S, Shahryari V,
Hirata H, Tanaka Y and Dahiya R: MicroRNA-708 induces apoptosis and
suppresses tumorigenicity in renal cancer cells. Cancer Res.
71:6208–6219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lian JH, Wang WH, Wang JQ, Zhang YH and Li
Y: MicroRNA-122 promotes proliferation, invasion and migration of
renal cell carcinoma cells through the PI3K/Akt signaling pathway.
Asian Pac J Cancer Prev. 14:5017–5021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu ZH, Zhang Q, Wang YD, Chen J, Jiang ZM,
Shi M, Guo X, Qin J, Cui GH, Cai ZM, et al: Overexpression of
cyclooxygenase-1 correlates with poor prognosis in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:3729–3734. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang Z, Chu PG, Woda BA, Liu Q, Balaji
KC, Rock KL and Wu CL: Combination of quantitative IMP3 and tumor
stage: A new system to predict metastasis for patients with
localized renal cell carcinomas. Clin Cancer Res. 14:5579–5584.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu D, Li M, Wang L, Zhou Y, Zhou J, Pan H
and Qu P: MicroRNA-145 inhibits cell proliferation, migration and
invasion by targeting matrix metallopeptidase-11 in renal cell
carcinoma. Mol Med Rep. 10:393–398. 2014.PubMed/NCBI
|
|
7
|
Li M, Wang Y, Song Y, Bu R, Yin B, Fei X,
Guo Q and Wu B: MicroRNAs in renal cell carcinoma: A systematic
review of clinical implications (Review). Oncol Rep. 33:1571–1578.
2015.PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dang Y, Zhao S, Qin Y, Han T, Li W and
Chen ZJ: MicroRNA-22-3p is down-regulated in the plasma of Han
Chinese patients with premature ovarian failure. Fertil Steril.
103:802–807. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang ZP and Wang DZ: MiR-22 in cardiac
remodeling and disease. Trends Cardiovasc Med. 24:267–272. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar :
|
|
13
|
Kwak PB, Iwasaki S and Tomari Y: The
microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Bo L, Zhao X and Chen Q:
MicroRNA-133a inhibits cell proliferation, colony formation
ability, migration and invasion by targeting matrix
metallopeptidase 9 in hepatocellular carcinoma. Mol Med Rep.
11:3900–3907. 2015.PubMed/NCBI
|
|
15
|
Eacker SM, Dawson TM and Dawson VL:
Understanding microRNAs in neurodegeneration. Nat Rev Neurosci.
10:837–841. 2009.PubMed/NCBI
|
|
16
|
Li B, Song Y, Liu TJ, Cui YB, Jiang Y, Xie
ZS and Xie SL: MiRNA-22 suppresses colon cancer cell migration and
invasion by inhibiting the expression of T-cell lymphoma invasion
and metastasis 1 and matrix metalloproteinases 2 and 9. Oncol Rep.
29:1932–1938. 2013.PubMed/NCBI
|
|
17
|
Guo MM, Hu LH, Wang YQ, Chen P, Huang JG,
Lu N, He JH and Liao CG: MiR-22 is down-regulated in gastric
cancer, and its overexpression inhibits cell migration and invasion
via targeting transcription factor Sp1. Med Oncol. 30:5422013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Liang S, Yu H, Zhang J, Ma D and Lu
X: An inhibitory effect of miR-22 on cell migration and invasion in
ovarian cancer. Gynecol Oncol. 119:543–548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu
S, Wu M, Pan Z and Zhou W: MicroRNA-22, downregulated in
hepatocellular carcinoma and correlated with prognosis, suppresses
cell proliferation and tumourigenicity. Br J Cancer. 103:1215–1220.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ling B, Wang GX, Long G, Qiu JH and Hu ZL:
Tumor suppressor miR-22 suppresses lung cancer cell progression
through post-transcriptional regulation of ErbB3. J Cancer Res Clin
Oncol. 138:1355–1361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tao J, Lu Q, Wu D, Li P, Xu B, Qing W,
Wang M, Zhang Z and Zhang W: microRNA-21 modulates cell
proliferation and sensitivity to doxorubicin in bladder cancer
cells. Oncol Rep. 25:1721–1729. 2011.PubMed/NCBI
|
|
22
|
Wang X, Yu H, Lu X, Zhang P, Wang M and Hu
Y: MiR-22 suppresses the proliferation and invasion of gastric
cancer cells by inhibiting CD151. Biochem Biophys Res Commun.
445:175–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rizvi MM, Alam MS, Mehdi SJ, Ali A and
Batra S: Allelic loss of 10q23.3, the PTEN gene locus in cervical
carcinoma from northern indian population. Pathol Oncol Res.
18:309–313. 2012. View Article : Google Scholar
|
|
24
|
Cheng T, Zhang JG, Cheng YH, Gao ZW and
Ren XQ: Relationship between PTEN and Livin expression and
malignancy of renal cell carcinomas. Asian Pac J Cancer Prev.
13:2681–2685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gu J, Tamura M and Yamada KM: Tumor
suppressor PTEN inhibits integrin- and growth factor-mediated
mitogen-activated protein (MAP) kinase signaling pathways. J Cell
Biol. 143:1375–1383. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brenner W, Färber G, Herget T, Lehr HA,
Hengstler JG and Thüroff JW: Loss of tumor suppressor protein PTEN
during renal carcinogenesis. Int J Cancer. 99:53–57. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun H, Lesche R, Li DM, Liliental J, Zhang
H, Gao J, Gavrilova N, Mueller B, Liu X and Wu H: PTEN modulates
cell cycle progression and cell survival by regulating
phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B
signaling pathway. Proc Natl Acad Sci USA. 96:6199–6204. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hager M, Haufe H, Kemmerling R, Mikuz G,
Kolbitsch C and Moser PL: PTEN expression in renal cell carcinoma
and oncocytoma and prognosis. Pathology. 39:482–485. 2007.
View Article : Google Scholar : PubMed/NCBI
|
